Fu'an Pharmaceutical Co., 33.4 million shares of the proposed March 14 purchase

Fu'an Pharmaceutical (300194) issued a letter of intent on the giant Tide information network in late Thursday. The company plans to issue no more than 33.4 million shares, issued after the total share capital of not more than 133.4 million shares.　　The unit will be implemented on March 14 online, web-based purchase, and will be listed on the gem.　　In this issue, the net issue accounted for the final issue of the number of 19.85%, that is, 6.63 million shares, the number of online distribution for the issue of the final release quantity minus the net final issue quantity.　　According to the issue schedule, the time for this inquiry is March 7-March 9, the issue of the publication date of March 11, the date of purchase and payment date is March 14.　　Chongqing Fu'an Pharmaceutical (Group) Co., Ltd. is mainly engaged in the development of antibiotic raw materials and preparations, production and sales, the main products include ammonia aztreonam raw materials and preparations, for ticarcillin sodium, sulfonic sodium raw materials, acetamiprid, cefotaxime sodium preparation, of which ammonia aztreonam raw materials and preparations for the company's leading products. The release of the funds will be invested in antibiotic raw materials, antibiotics and new product development related to five projects, the total investment of 408 million yuan, the remainder will be used for other business related to the operating capital.